Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis

Mafficini, A.;Ortombina, M.;Sermet-Gaudelus, I.;Lebecque, Patrick;Melotti, P.;et.al.
(2009) 32nd European Cystic Fibrosis Conference — Location: (France) Brest (10.June.2009)

Files

document.pdf
  • Restricted Access
  • Adobe PDF
  • 62.15 KB

Details

Authors
  • Mafficini, A.
    Author
  • Ortombina, M.
    Author
  • Sermet-Gaudelus, I.
    Author
  • Lebecque, PatrickUCLouvain
    Author
  • Author
  • Author
  • Dahan, KarinUCLouvain
    Author
  • Melotti, P.
    Author
Show more
Affiliations

Citations

Mafficini, A., Ortombina, M., Sermet-Gaudelus, I., Lebecque, P., Leal, T., Leonard, A., Reychler, G., Dahan, K., Pepermans, X., Lenoir, G., Sorio, C., Iansa, P., Assael, B. M., & Melotti, P. (2009). Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis. Journal of Cystic Fibrosis, 8(Suppl 1), S4. https://doi.org/10.1016/s1569-1993(09)60024-2 (Original work published 2009)